East Bay's Scribe Therapeutics lands 2nd big deal with Sanofi, this one aimed initially at sickle cell disease

It is the second deal within a year between the company, co-founded by Nobel laureate Jennifer Doudna, and Sanofi.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 17, 2023 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news